Stuart J. Schnitt

Active 1984–2025

200
Papers
40,208
Citations
110
h-index
195
i10-index

Citations

Citations per year for Stuart J. Schnitt1984: 1 citations1985: 10 citations1986: 13 citations1987: 25 citations1988: 27 citations1989: 43 citations1990: 54 citations1991: 39 citations1992: 48 citations1993: 49 citations1994: 45 citations1995: 64 citations1996: 63 citations1997: 78 citations1998: 103 citations1999: 106 citations2000: 157 citations2001: 182 citations2002: 172 citations2003: 189 citations2004: 176 citations2005: 203 citations2006: 203 citations2007: 250 citations2008: 328 citations2009: 291 citations2010: 339 citations2011: 322 citations2012: 293 citations2013: 269 citations2014: 352 citations2015: 386 citations2016: 340 citations2017: 330 citations2018: 361 citations2019: 939 citations2020: 1,071 citations2021: 1,021 citations2022: 777 citations2023: 561 citations2024: 875 citations2025: 432 citations2026: 31 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,540 citing papers, 30.4% of this breakdownChina: 1,166 citing papers, 7.8% of this breakdownUnited Kingdom: 949 citing papers, 6.4% of this breakdownItaly: 764 citing papers, 5.1% of this breakdownGermany: 566 citing papers, 3.8% of this breakdownCanada: 506 citing papers, 3.4% of this breakdownFrance: 488 citing papers, 3.3% of this breakdownAustralia: 440 citing papers, 3% of this breakdownNetherlands: 440 citing papers, 2.9% of this breakdownJapan: 396 citing papers, 2.7% of this breakdownSpain: 311 citing papers, 2.1% of this breakdownSwitzerland: 287 citing papers, 1.9% of this breakdown
0%30.4%Other 27.2%

Fields

  • Medicine47.3%
  • Biochemistry, Genetics and Molecular Biology39.1%
  • Computer Science7.3%
  • Immunology and Microbiology2.6%
  • Engineering1.2%
  • Neuroscience0.5%
  • Other2%

Topics

  • Breast Cancer Treatment Studies9.2%
  • Breast Lesions and Carcinomas5.6%
  • Cancer Cells and Metastasis4.7%
  • AI in cancer detection3.7%
  • HER2/EGFR in Cancer Research3.3%
  • Cancer Genomics and Diagnostics2.6%
  • Other70.9%

Coauthors

All papers

Open in search
  1. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fabrice André, G. Curigliano - Annals of Oncology 2023 cited by 299

  2. The 2019 World Health Organization classification of tumours of the breast

    Authors: , , , , , , , , , , , , , , , , , , - Histopathology 2020 cited by 1,074

  3. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  4. Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens

    Authors: , , , , , , , , , , , - JAMA 2015 cited by 723

  5. A Nonapoptotic Cell Death Process, Entosis, that Occurs by Cell-in-Cell Invasion

    Authors: , , , , , , , - Cell 2007 cited by 749

  6. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 720

  7. Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

    Authors: , , , , , , , , , , , , , , , - JAMA Oncology 2022 cited by 202

  8. Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies

    Authors: , , , , , , , , , , , , , , - npj Breast Cancer 2022 cited by 103

  9. Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent A. Miller - Clinical Cancer Research 2014 cited by 662

  10. Breast cancer prognostic classification in the molecular era: the role of histological grade

    Authors: , , , , , , , , , , , , , , , , , - Breast Cancer Research 2010 cited by 992

  11. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, the International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo and 156 more - npj Breast Cancer 2020 cited by 206

  12. Molecular analysis of TCGA breast cancer histologic types

    Authors: , , , , , , , , , , , - Cell Genomics 2021 cited by 116

  13. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giancarlo Pruneri, Sandra Demaria, Sylvia Adams, Stuart J. Schnitt, Sunil R. Lakhani, Federico Rojo, Laura Comerma, Sunil Badve, Mehrnoush Khojasteh, W. Fraser Symmans, Christos Sotiriou, Paula I. González-Ericsson, Katherine L. Pogue–Geile, Rim S. Kim, David L. Rimm, Giuseppe Viale, Stephen M. Hewitt, John M. S. Bartlett, Frédérique Penault–Llorca, Shom Goel, Huang‐Chun Lien, Sibylle Loibl, Zuzana Kos, Sherene Loi, Matthew G. Hanna, Stefan Michiels, Marleen Kok, Torsten O. Nielsen, Alexander J. Lazar, Zsuzsanna Bagó-Horváth, Loes Kooreman, Jeroen van der Laak, Joel Saltz, Brandon D. Gallas, Uday Kurkure, Michael Barnes, Roberto Salgado, Lee Cooper, International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair M. Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo, Anna Sapino, André L. Moreira, Andrea L. Richardson, Andrea Vingiani, Andrew M. Bellizzi, Andrew Tutt, Ángel Guerrero‐Zotano, Anita Grigoriadis, Anna Ehinger, Ana C. Garrido-Castro, Anne Vincent-Salomon, Anne‐Vibeke Lænkholm, Ashley Cimino‐Mathews, Ashok Srinivasan, Balázs Ács, Baljit Singh, Benjamin C. Calhoun, Benjamin Haibe-Kans, Benjamin Solomon, Bibhusal Thapa, Brad H. Nelson, Carlos Castaneda, Carmen Ballesteroes-Merino, Carmen Criscitiello, Carolien Boeckx and 158 more - npj Breast Cancer 2020 cited by 166

  14. Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicolas Sirtaine, Sandra A. O’Toole, Giuseppe Viale, Koen Van de Vijver, Roland de Wind, Gϋnter von Minckwitz, Frederick Klauschen, Michael Untch, Peter A. Fasching, Toralf Reimer, Karen Willard‐Gallo, Stefan Michiels, Sherene Loi, Roberto Salgado - Modern Pathology 2016 cited by 279

  15. Molecular Definition of Breast Tumor Heterogeneity

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2007 cited by 1,353

  16. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Authors: , , , , , , , , , , , , , , , , , , - Modern Pathology 2010 cited by 674

  17. Artificial intelligence applied to breast pathology

    Authors: , , , , , , , - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2021 cited by 85

  18. Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy

    Authors: , , , , , , , , , , , , , - Nature Biotechnology 2017 cited by 244

  19. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carlos Castaneda, Marleen Kok, Heather L. McArthur, Kalliopi P. Siziopikou, Sunil Badve, Susan Fineberg, Allen M. Gown, Giuseppe Viale, Stuart J. Schnitt, Giancarlo Pruneri, Frederique Penault‐Llorca, Stephen M. Hewitt, E. Aubrey Thompson, Kimberly H. Allison, W. Fraser Symmans, Andrew M. Bellizzi, Edi Brogi, David A. Moore, Denis Larsimont, Deborah Dillon, Alexander J. Lazar, Huang‐Chun Lien, Matthew P. Goetz, Glenn Broeckx, Khalid El Bairi, Nadia Harbeck, Ashley Cimino‐Mathews, Christos Sotiriou, Sylvia Adams, S Liu, Sibylle Loibl, I‐Chun Chen, Sunil R. Lakhani, Jonathan Juco, Carsten Denkert, Elizabeth F. Blackley, Sandra Demaria, Roberto A. Leon‐Ferre, Oleg Gluz, Dimitrios Zardavas, Kenneth Emancipator, Scott Ely, Sherene Loi, Roberto Salgado, Melinda E. Sanders, International Immuno‐Oncology Biomarker Working Group - The Journal of Pathology 2020 cited by 226

  20. Molecular characterization of the tumor microenvironment in breast cancer

    Authors: , , , , , , , , , , , , - Cancer Cell 2004 cited by 1,303

  21. Phyllodes tumours of the breast: a consensus review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Histopathology 2015 cited by 495

  22. The Spectrum of Triple-Negative Breast Disease

    Authors: , , , , , , - American Journal Of Pathology 2017 cited by 179

  23. TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 130

  24. Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick W.B. Derksen, Giuseppe Floris, Christine Desmedt - Modern Pathology 2022 cited by 42